BioLongevity Labs score history
Every recorded change to BioLongevity Labs’s overall score since July 23, 2026, with the audit note written at the time. Scores follow our published methodology; affiliate status never affects them.
- Score today
- 7.24/10
Score today
- Score changes
- 17
Score changes
- Audit entries
- 18
Audit entries
Score over time
Every entry newest first
- Lowered from7.26to7.24(-0.02)
Pricing re-checked on 6 November 2026 after the market medians were recalculated with GhostLabz and NextSelf Labs added pricing 3.4 to 3.3.
- Raised from7.24to7.26(+0.02)
Pricing re-checked on 5 November 2026 after the market medians were recalculated with Peptyes added pricing 3.3 to 3.4.
- Raised from7.23to7.24(+0.01)
Pricing re-checked on 5 November 2026 after the market medians were recalculated pricing 3.2 to 3.3.
- Lowered from7.29to7.23(-0.06)
Market medians updated after the 2 November re-checks pricing 3.6 to 3.2.
- Lowered from7.32to7.29(-0.03)
Pricing recomputed on 26 October 2026: listings added for a newly reviewed vendor (StudzPeptides) moved the market median for the same products: pricing 3.8 to 3.6.
- Lowered from7.35to7.32(-0.03)
Pricing recomputed on 24 October 2026: listings added for newly reviewed vendors moved the market median for the same products: pricing 4.0 to 3.8.
- Raised from7.32to7.35(+0.03)
Pricing recomputed on 23 October 2026 from current listings with the published rule (section E), after listings added or updated since 22 October, including a newly reviewed vendor's, moved the market median for the same products: pricing 3.8 to 4.0.
- Lowered from7.54to7.32(-0.22)
Laboratory rule change on 22 October 2026: the accreditation point (+1) now applies only to a certificate tested on or after the date from which the accrediting body's register shows the accreditation as active. MDx BioAnalytical Laboratory's PJLA accreditation (certificate L26-502) is active from 9 June 2026, and 15 of BioLongevity Labs' MDx certificates were tested before that date, so they no longer earn the point. Lab 8.5 to 8.1.
- Raised from7.37to7.54(+0.17)
BioRegen certificates confirmed at the laboratory's own lookup on 22 October 2026 (an invented test key returned no match), so they now receive the confirmed-key credit under our published lab rule. Lab 8.2 to 8.5.
- Re-checked, no change (7.37)
Operating history re-checked on 22 October 2026 under the published rule (earliest dated evidence of the business, including the named operating company, looked up for every vendor): the Ohio Secretary of State shows F2 Nutrition, LLC, the operator the site names, formed on 26 February 2014, earlier than the archived store used before. Operating history 9.2 to 9.3. The overall score was unchanged at 7.37 because the testing-gate cap applied at the time.
- Lowered from7.57to7.37(-0.20)
Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: shipping and refunds 8.5 to 7.5.
- Raised from7.40to7.57(+0.17)
Re-scored on 22 October 2026 under version 2 of our published rules. The deduction for verification codes the laboratory could not find was retired: each such certificate now keeps its points for the printed key and earns none for confirmation, and codes on certificates we do not score no longer count. The testing gate is now computed from the certificates: 16 of 35 products have a certificate confirmed at a directory laboratory, fewer than the half required, so the cap applies; it sits above the weighted score, so it does not lower it. Lab 7.9 to 8.2. Score 7.40 to 7.57.
- Raised from7.07to7.40(+0.33)
MDx BioAnalytical Laboratory confirmed accredited in PJLA's register on 22 October 2026 (certificate L26-502, scope includes peptides and endotoxins), so its certificates now receive the accreditation credit under our published lab rule. Lab 7.3 to 7.9.
- Raised from6.96to7.07(+0.11)
Laboratory directory completed on 22 October 2026: AV Analytics and Analiza Bialek were researched and added under the published lab criteria, so their certificates now receive the recognised-laboratory credit. Lab 7.1 to 7.3.
- Lowered from7.67to6.96(-0.71)
Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 9.5 to 8.5, pricing 5.9 to 3.8, operating history 9.5 to 9.2, transparency 10.0 to 6.5.
- Lowered from7.83to7.67(-0.16)
Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for certificates more than 12 months old, site statements about testing that the certificates do not bear out and verification codes the issuing laboratory could not find. Lab 7.4 to 7.1.
- Lowered from7.94to7.83(-0.11)
Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 35 of the 36 products we list that the vendor offers for sale. Lab 7.6 to 7.4.
- Raised from7.88to7.94(+0.06)
Re-audited from live COAs. Corrected the lab of record from SafeCert to MDx BioAnalytical (2026, with endotoxin) plus BioRegen legacy reports, for a small lab-rating gain. Several overfilled batches were documented.
Score changes for every vendor are on the score changes page. BioLongevity Labs may display its current score with the score badge, which updates automatically and has no effect on the score.